To help stakeholders stay informed of the latest developments and gain insights into market trends, this article provides a systematic review and in-depth analysis of the cosmetic ingredient filings published by China’s National Medical Products Administration (NMPA) in November 2025. The report mainly covers the number of new ingredient filings during the month, basic information about the filing enterprises, the regional distribution of domestic filers, ingredients that have been filed multiple times, and interpretations of selected ingredients. It aims to offer valuable data support and information references for the cosmetics industry.

To help stakeholders stay informed of the latest developments and gain insights into market trends, this article provides a systematic review and in-depth analysis of the cosmetic ingredient filings published by China’s National Medical Products Administration (NMPA) in October 2025. The report mainly covers the number of new ingredient filings during the month, basic information about the filing enterprises, the regional distribution of domestic filers, ingredients that have been filed multiple times, and interpretations of selected ingredients. It aims to offer valuable data support and information references for the cosmetics industry.

This article compiles and summarizes the latest developments in cosmetics regulations in China and globally as of October 2025, covering industry news, newly issued regulations, relevant policy adjustments, and regulatory requirements. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.

China’s NMPA has issued 24 new measures to reform cosmetics regulation. Explore the key changes, impacts on innovation, registration, safety, and international alignment.

This article provides a consolidated overview of the relevant regulatory notices, supplemented by recent developments in regulatory enforcement activities-such as unannounced inspections and sampling inspections-conducted by the National Medical Products Administration (NMPA) and selected provincial and municipal authorities. The aim is to assist enterprises in staying informed of evolving regulatory trends and to reinforce awareness of quality management and compliance requirements.

In Part I of this series, we introduced the evaluation methods for dandruff, sebum levels, and itchiness. In this article (Part II), we focus on the evaluation methods for erythema, papules, pustules, and the overall hair status.

On October 30, 2025, China’s National Medical Products Administration (NMPA) approved two new cosmetic ingredients for registration – a major step forward in China’s cosmetic ingredient innovation. Details and analysis below.

On July 31, 2025, in order to further regulate and guide the research and evaluation of sunscreen cosmetics, the Cosmetic Supervision Department under China's National Medical Products Administration (NMPA) organized the National Institutes for Food and Drug Control (NIFDC) to draft two technical guidelines: the Technical Guidelines for the Research of Sunscreen Cosmetics (Trial) (Draft for Comments) and the Technical Guidelines for the Research on Quality Control Standards of Sunscreen Cosmetics (Trial) (Draft for Comments), along with their respective drafting instructions. These documents have been released to the public for consultation.

To help stakeholders stay informed of the latest developments and gain insights into market trends, this article provides a systematic review and in-depth analysis of the cosmetic ingredient filings published by China’s National Medical Products Administration (NMPA) in September 2025. The report mainly covers the number of new ingredient filings during the month, basic information about the filing enterprises, the regional distribution of domestic filers, ingredients that have been filed multiple times, and interpretations of selected ingredients. It aims to offer valuable data support and information references for the cosmetics industry.

To enhance the implementation of China’s Cosmetics Supervision and Administration Regulations and promote ingredient innovation, the National Medical Products Administration (NMPA) has released Announcement No. 61 of 2025. This update introduces a dynamic adjustment mechanism for the Inventory of Existing Cosmetic Ingredients (IECIC) – enabling continuous updates, improved accuracy, and better alignment with global cosmetic safety practices. The move marks a major step toward more transparent and science-driven cosmetic ingredient management in China. To clarify key management issues related to the IECIC, the NMPA has issued a series of official responses. The cosmetic team at CIRS Group has compiled and translated these explanations for industry reference.